Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 7.55514206 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.55514206 |
3 | L-phenylalanine metabolic process (GO:0006558) | 7.18203206 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.18203206 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.54490737 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.29256206 |
7 | glyoxylate metabolic process (GO:0046487) | 5.69657948 |
8 | regulation of plasminogen activation (GO:0010755) | 5.67437577 |
9 | bile acid biosynthetic process (GO:0006699) | 5.67178675 |
10 | alpha-linolenic acid metabolic process (GO:0036109) | 5.64671873 |
11 | indole-containing compound catabolic process (GO:0042436) | 5.63093993 |
12 | indolalkylamine catabolic process (GO:0046218) | 5.63093993 |
13 | tryptophan catabolic process (GO:0006569) | 5.63093993 |
14 | negative regulation of fibrinolysis (GO:0051918) | 5.62678921 |
15 | complement activation, alternative pathway (GO:0006957) | 5.58836660 |
16 | kynurenine metabolic process (GO:0070189) | 5.57174684 |
17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.57058868 |
18 | regulation of protein activation cascade (GO:2000257) | 5.56761918 |
19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.43958599 |
20 | protein carboxylation (GO:0018214) | 5.43958599 |
21 | urea metabolic process (GO:0019627) | 5.37716945 |
22 | urea cycle (GO:0000050) | 5.37716945 |
23 | tryptophan metabolic process (GO:0006568) | 5.37217737 |
24 | regulation of fibrinolysis (GO:0051917) | 5.36641275 |
25 | cysteine metabolic process (GO:0006534) | 5.26554190 |
26 | sulfur amino acid catabolic process (GO:0000098) | 5.22159993 |
27 | epoxygenase P450 pathway (GO:0019373) | 5.18701134 |
28 | regulation of complement activation (GO:0030449) | 5.16995056 |
29 | regulation of apoptotic cell clearance (GO:2000425) | 5.10810207 |
30 | intestinal cholesterol absorption (GO:0030299) | 5.09583098 |
31 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.08232737 |
32 | regulation of cholesterol esterification (GO:0010872) | 5.04633570 |
33 | reverse cholesterol transport (GO:0043691) | 5.03409016 |
34 | bile acid metabolic process (GO:0008206) | 4.97049151 |
35 | regulation of humoral immune response (GO:0002920) | 4.94048176 |
36 | protein-lipid complex remodeling (GO:0034368) | 4.93371964 |
37 | macromolecular complex remodeling (GO:0034367) | 4.93371964 |
38 | plasma lipoprotein particle remodeling (GO:0034369) | 4.93371964 |
39 | nitrogen cycle metabolic process (GO:0071941) | 4.92550471 |
40 | aromatic amino acid family metabolic process (GO:0009072) | 4.87730384 |
41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.83897074 |
42 | negative regulation of hemostasis (GO:1900047) | 4.80773820 |
43 | negative regulation of blood coagulation (GO:0030195) | 4.80773820 |
44 | tyrosine metabolic process (GO:0006570) | 4.80343694 |
45 | regulation of triglyceride catabolic process (GO:0010896) | 4.75598674 |
46 | serine family amino acid catabolic process (GO:0009071) | 4.74891660 |
47 | negative regulation of complement activation (GO:0045916) | 4.72431829 |
48 | homocysteine metabolic process (GO:0050667) | 4.70153142 |
49 | phospholipid efflux (GO:0033700) | 4.69197490 |
50 | acylglycerol homeostasis (GO:0055090) | 4.64866068 |
51 | triglyceride homeostasis (GO:0070328) | 4.64866068 |
52 | drug catabolic process (GO:0042737) | 4.52738273 |
53 | positive regulation of blood coagulation (GO:0030194) | 4.44756573 |
54 | positive regulation of hemostasis (GO:1900048) | 4.44756573 |
55 | alpha-amino acid catabolic process (GO:1901606) | 4.41984257 |
56 | bile acid and bile salt transport (GO:0015721) | 4.41901303 |
57 | negative regulation of coagulation (GO:0050819) | 4.40074150 |
58 | cholesterol efflux (GO:0033344) | 4.39496649 |
59 | amino-acid betaine metabolic process (GO:0006577) | 4.39184502 |
60 | lysine metabolic process (GO:0006553) | 4.36380511 |
61 | lysine catabolic process (GO:0006554) | 4.36380511 |
62 | negative regulation of cholesterol transport (GO:0032375) | 4.35756092 |
63 | negative regulation of sterol transport (GO:0032372) | 4.35756092 |
64 | plasma lipoprotein particle clearance (GO:0034381) | 4.33938286 |
65 | indolalkylamine metabolic process (GO:0006586) | 4.33528766 |
66 | negative regulation of wound healing (GO:0061045) | 4.31848819 |
67 | cellular ketone body metabolic process (GO:0046950) | 4.30357727 |
68 | omega-hydroxylase P450 pathway (GO:0097267) | 4.28209057 |
69 | coenzyme catabolic process (GO:0009109) | 4.23730154 |
70 | low-density lipoprotein particle remodeling (GO:0034374) | 4.19064419 |
71 | exogenous drug catabolic process (GO:0042738) | 4.15201354 |
72 | glutamate metabolic process (GO:0006536) | 4.11894563 |
73 | plasma lipoprotein particle assembly (GO:0034377) | 4.10764343 |
74 | positive regulation of coagulation (GO:0050820) | 4.08994533 |
75 | uronic acid metabolic process (GO:0006063) | 4.08538607 |
76 | glucuronate metabolic process (GO:0019585) | 4.08538607 |
77 | cellular amino acid catabolic process (GO:0009063) | 4.08494904 |
78 | fibrinolysis (GO:0042730) | 4.07879715 |
79 | glycine metabolic process (GO:0006544) | 4.04964550 |
80 | imidazole-containing compound metabolic process (GO:0052803) | 4.01710220 |
81 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.99044107 |
82 | ethanol metabolic process (GO:0006067) | 3.98825912 |
83 | phospholipid homeostasis (GO:0055091) | 3.92385453 |
84 | cellular glucuronidation (GO:0052695) | 3.92296001 |
85 | cellular modified amino acid catabolic process (GO:0042219) | 3.91610679 |
86 | serine family amino acid metabolic process (GO:0009069) | 3.86433770 |
87 | aldehyde catabolic process (GO:0046185) | 3.85781745 |
88 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.84029516 |
89 | amine catabolic process (GO:0009310) | 3.81822192 |
90 | cellular biogenic amine catabolic process (GO:0042402) | 3.81822192 |
91 | benzene-containing compound metabolic process (GO:0042537) | 3.80743475 |
92 | complement activation, classical pathway (GO:0006958) | 3.79465536 |
93 | positive regulation of lipid catabolic process (GO:0050996) | 3.78269836 |
94 | plasma lipoprotein particle organization (GO:0071827) | 3.77905067 |
95 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76579604 |
96 | negative regulation of lipase activity (GO:0060192) | 3.76268428 |
97 | blood coagulation, intrinsic pathway (GO:0007597) | 3.74371384 |
98 | cytolysis (GO:0019835) | 3.73797481 |
99 | proline metabolic process (GO:0006560) | 3.73233436 |
100 | acute-phase response (GO:0006953) | 3.72226863 |
101 | complement activation (GO:0006956) | 3.71739327 |
102 | ketone body metabolic process (GO:1902224) | 3.70818280 |
103 | negative regulation of protein activation cascade (GO:2000258) | 3.70014948 |
104 | protein activation cascade (GO:0072376) | 3.69519919 |
105 | protein-lipid complex assembly (GO:0065005) | 3.69367078 |
106 | negative regulation of humoral immune response (GO:0002921) | 3.68754734 |
107 | ethanol oxidation (GO:0006069) | 3.68652000 |
108 | positive regulation of extracellular matrix organization (GO:1903055) | 3.68130393 |
109 | cholesterol homeostasis (GO:0042632) | 3.67677085 |
110 | opsonization (GO:0008228) | 3.65872795 |
111 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.65830298 |
112 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.65830298 |
113 | drug metabolic process (GO:0017144) | 3.65682103 |
114 | serine family amino acid biosynthetic process (GO:0009070) | 3.65197909 |
115 | arginine metabolic process (GO:0006525) | 3.65059300 |
116 | cofactor catabolic process (GO:0051187) | 3.64635791 |
117 | lipoprotein metabolic process (GO:0042157) | 3.63389961 |
118 | sterol homeostasis (GO:0055092) | 3.61747787 |
119 | drug transmembrane transport (GO:0006855) | 3.60317207 |
120 | regulation of bile acid biosynthetic process (GO:0070857) | 3.60112168 |
121 | organic acid catabolic process (GO:0016054) | 3.59672540 |
122 | carboxylic acid catabolic process (GO:0046395) | 3.59672540 |
123 | acute inflammatory response (GO:0002526) | 3.58537005 |
124 | regulation of cholesterol homeostasis (GO:2000188) | 3.56929843 |
125 | protein-lipid complex subunit organization (GO:0071825) | 3.55987899 |
126 | sterol transport (GO:0015918) | 3.54852533 |
127 | cholesterol transport (GO:0030301) | 3.54852533 |
128 | short-chain fatty acid metabolic process (GO:0046459) | 3.52241064 |
129 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.47902596 |
130 | phenylpropanoid metabolic process (GO:0009698) | 3.42515988 |
131 | intestinal absorption (GO:0050892) | 3.39190564 |
132 | diacylglycerol metabolic process (GO:0046339) | 3.38706152 |
133 | regulation of acute inflammatory response (GO:0002673) | 3.32867969 |
134 | peptidyl-glutamic acid modification (GO:0018200) | 3.26542382 |
135 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.22540344 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.11209316 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.90919429 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.60053030 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.36270324 |
5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.08760695 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.05563899 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.33291781 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.05761685 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.97615038 |
10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.09760391 |
11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07426761 |
12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6515532 |
13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.98770477 |
14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98732075 |
15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98495601 |
16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89890502 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.83405529 |
18 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.75165580 |
19 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.69793571 |
20 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.55296038 |
21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44672638 |
22 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.42403765 |
23 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41050691 |
24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.25332974 |
25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25170964 |
26 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.23318611 |
27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16777907 |
28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.16104275 |
29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15598798 |
30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07810871 |
31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04463521 |
32 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04337828 |
33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00750348 |
34 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00312958 |
35 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96459061 |
36 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93653713 |
37 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93653713 |
38 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92416788 |
39 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90927726 |
40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90215875 |
41 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.89296547 |
42 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88358204 |
43 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87062370 |
44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83258376 |
45 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.83236190 |
46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.82256785 |
47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80574692 |
48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77487005 |
49 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.76799592 |
50 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73671544 |
51 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.73573207 |
52 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.73108078 |
53 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.72768594 |
54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.70445628 |
55 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70173312 |
56 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69118911 |
57 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.67617086 |
58 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.67126518 |
59 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.66404935 |
60 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.65382500 |
61 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.64678818 |
62 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.64020236 |
63 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.63937913 |
64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63429058 |
65 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.62702423 |
66 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.62612046 |
67 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62468568 |
68 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.61532480 |
69 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.61449200 |
70 | AR_20517297_ChIP-Seq_VCAP_Human | 0.61038636 |
71 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.60927109 |
72 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.59806090 |
73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.59793870 |
74 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.59569769 |
75 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58963258 |
76 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.58655268 |
77 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.58566971 |
78 | TP53_16413492_ChIP-PET_HCT116_Human | 0.58545263 |
79 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.58250271 |
80 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.58145211 |
81 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.57526750 |
82 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.57229406 |
83 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.56877314 |
84 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.56770208 |
85 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.56197415 |
86 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.55716851 |
87 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.55187369 |
88 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.55021246 |
89 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.54888495 |
90 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.54637978 |
91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.54479605 |
92 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.54393946 |
93 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.53550080 |
94 | CBP_21632823_ChIP-Seq_H3396_Human | 0.53543842 |
95 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.53370260 |
96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.53361089 |
97 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.52958097 |
98 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52664941 |
99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.52305924 |
100 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.52190812 |
101 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.51808869 |
102 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.51716771 |
103 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.51469460 |
104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.51370477 |
105 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.51366805 |
106 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51243899 |
107 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.51111477 |
108 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.50883327 |
109 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.50014132 |
110 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.49619704 |
111 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.49408847 |
112 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.49187421 |
113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.48858709 |
114 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.48718408 |
115 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.48239904 |
116 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.47396896 |
117 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.47331470 |
118 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.47328483 |
119 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.46782117 |
120 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.46653802 |
121 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.45693782 |
122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.45686104 |
123 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.43321845 |
124 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.42965514 |
125 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.42835877 |
126 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.42622194 |
127 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.42600947 |
128 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42446104 |
129 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.42149158 |
130 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41962767 |
131 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.41701491 |
132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41337618 |
133 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.41133096 |
134 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.41085645 |
135 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.41001018 |
136 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.40894844 |
137 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.40043199 |
138 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.39784381 |
139 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.39591876 |
140 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.39045266 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.95893804 |
2 | MP0005360_urolithiasis | 7.10866852 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.46173889 |
4 | MP0005365_abnormal_bile_salt | 6.31582702 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.73876588 |
6 | MP0003252_abnormal_bile_duct | 4.22997994 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.91190151 |
8 | MP0010329_abnormal_lipoprotein_level | 3.55200791 |
9 | MP0003122_maternal_imprinting | 3.21101272 |
10 | MP0003195_calcinosis | 3.07051913 |
11 | MP0009840_abnormal_foam_cell | 3.05995642 |
12 | MP0005083_abnormal_biliary_tract | 2.98575517 |
13 | MP0005332_abnormal_amino_acid | 2.71820601 |
14 | MP0001666_abnormal_nutrient_absorption | 2.61266342 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.40673991 |
16 | MP0002138_abnormal_hepatobiliary_system | 2.16721477 |
17 | MP0000609_abnormal_liver_physiology | 2.16128884 |
18 | MP0004019_abnormal_vitamin_homeostasis | 2.11393645 |
19 | MP0002118_abnormal_lipid_homeostasis | 2.09861777 |
20 | MP0003868_abnormal_feces_composition | 2.09034324 |
21 | MP0001915_intracranial_hemorrhage | 1.81738393 |
22 | MP0005319_abnormal_enzyme/_coenzyme | 1.78120990 |
23 | MP0001764_abnormal_homeostasis | 1.68070792 |
24 | MP0002132_abnormal_respiratory_system | 1.66352543 |
25 | MP0003123_paternal_imprinting | 1.58726819 |
26 | MP0002089_abnormal_postnatal_growth/wei | 1.52255120 |
27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46523938 |
28 | MP0002909_abnormal_adrenal_gland | 1.40300138 |
29 | MP0009697_abnormal_copulation | 1.37833190 |
30 | MP0009643_abnormal_urine_homeostasis | 1.37824395 |
31 | MP0002254_reproductive_system_inflammat | 1.29301769 |
32 | MP0000566_synostosis | 1.28767085 |
33 | MP0002837_dystrophic_cardiac_calcinosis | 1.23228223 |
34 | MP0004272_abnormal_basement_membrane | 1.20496851 |
35 | MP0003172_abnormal_lysosome_physiology | 1.19492206 |
36 | MP0003656_abnormal_erythrocyte_physiolo | 1.19358346 |
37 | MP0000604_amyloidosis | 1.17514586 |
38 | MP0000598_abnormal_liver_morphology | 1.15962653 |
39 | MP0003186_abnormal_redox_activity | 1.11264134 |
40 | MP0003011_delayed_dark_adaptation | 1.10572691 |
41 | MP0005451_abnormal_body_composition | 1.10492262 |
42 | MP0002078_abnormal_glucose_homeostasis | 1.10070581 |
43 | MP0005636_abnormal_mineral_homeostasis | 1.06951700 |
44 | MP0005220_abnormal_exocrine_pancreas | 1.04614734 |
45 | MP0009763_increased_sensitivity_to | 1.02629986 |
46 | MP0003705_abnormal_hypodermis_morpholog | 0.98031175 |
47 | MP0000639_abnormal_adrenal_gland | 0.97264281 |
48 | MP0002876_abnormal_thyroid_physiology | 0.95956543 |
49 | MP0005409_darkened_coat_color | 0.93663929 |
50 | MP0009764_decreased_sensitivity_to | 0.91607696 |
51 | MP0005647_abnormal_sex_gland | 0.91281330 |
52 | MP0009642_abnormal_blood_homeostasis | 0.90992729 |
53 | MP0005408_hypopigmentation | 0.90367353 |
54 | MP0005670_abnormal_white_adipose | 0.89599794 |
55 | MP0008469_abnormal_protein_level | 0.88431637 |
56 | MP0003121_genomic_imprinting | 0.86548386 |
57 | MP0005084_abnormal_gallbladder_morpholo | 0.85824541 |
58 | MP0001756_abnormal_urination | 0.84327301 |
59 | MP0004130_abnormal_muscle_cell | 0.81138445 |
60 | MP0006054_spinal_hemorrhage | 0.80885686 |
61 | MP0005376_homeostasis/metabolism_phenot | 0.80487799 |
62 | MP0005535_abnormal_body_temperature | 0.80299692 |
63 | MP0003941_abnormal_skin_development | 0.79538308 |
64 | MP0006036_abnormal_mitochondrial_physio | 0.79083567 |
65 | MP0009765_abnormal_xenobiotic_induced | 0.78405185 |
66 | MP0010368_abnormal_lymphatic_system | 0.77609448 |
67 | MP0005167_abnormal_blood-brain_barrier | 0.76540902 |
68 | MP0005334_abnormal_fat_pad | 0.75194692 |
69 | MP0003690_abnormal_glial_cell | 0.71075486 |
70 | MP0001661_extended_life_span | 0.70055959 |
71 | MP0002971_abnormal_brown_adipose | 0.69964428 |
72 | MP0005448_abnormal_energy_balance | 0.67281037 |
73 | MP0005257_abnormal_intraocular_pressure | 0.66244939 |
74 | MP0003183_abnormal_peptide_metabolism | 0.65846115 |
75 | MP0010234_abnormal_vibrissa_follicle | 0.63722899 |
76 | MP0005266_abnormal_metabolism | 0.62093998 |
77 | MP0003950_abnormal_plasma_membrane | 0.61876154 |
78 | MP0002928_abnormal_bile_duct | 0.61833032 |
79 | MP0001944_abnormal_pancreas_morphology | 0.61002507 |
80 | MP0003879_abnormal_hair_cell | 0.60907589 |
81 | MP0003329_amyloid_beta_deposits | 0.60710128 |
82 | MP0003953_abnormal_hormone_level | 0.59480826 |
83 | MP0002282_abnormal_trachea_morphology | 0.58682671 |
84 | MP0005379_endocrine/exocrine_gland_phen | 0.56922244 |
85 | MP0004264_abnormal_extraembryonic_tissu | 0.55492591 |
86 | MP0003567_abnormal_fetal_cardiomyocyte | 0.54263621 |
87 | MP0003632_abnormal_nervous_system | 0.53542571 |
88 | MP0000013_abnormal_adipose_tissue | 0.53237951 |
89 | MP0003724_increased_susceptibility_to | 0.53139892 |
90 | MP0003300_gastrointestinal_ulcer | 0.52658389 |
91 | MP0009384_cardiac_valve_regurgitation | 0.52203718 |
92 | MP0002933_joint_inflammation | 0.50440531 |
93 | MP0000920_abnormal_myelination | 0.50431796 |
94 | MP0005464_abnormal_platelet_physiology | 0.48888226 |
95 | MP0005187_abnormal_penis_morphology | 0.48435873 |
96 | MP0002938_white_spotting | 0.48366394 |
97 | MP0001324_abnormal_eye_pigmentation | 0.48140996 |
98 | MP0002136_abnormal_kidney_physiology | 0.48121947 |
99 | MP0009053_abnormal_anal_canal | 0.47587621 |
100 | MP0006035_abnormal_mitochondrial_morpho | 0.47234502 |
101 | MP0002693_abnormal_pancreas_physiology | 0.47191120 |
102 | MP0005058_abnormal_lysosome_morphology | 0.46286674 |
103 | MP0005395_other_phenotype | 0.45782582 |
104 | MP0005248_abnormal_Harderian_gland | 0.45686321 |
105 | MP0004782_abnormal_surfactant_physiolog | 0.45661274 |
106 | MP0004883_abnormal_blood_vessel | 0.45123987 |
107 | MP0008873_increased_physiological_sensi | 0.45105300 |
108 | MP0005023_abnormal_wound_healing | 0.44913775 |
109 | MP0003638_abnormal_response/metabolism_ | 0.44770812 |
110 | MP0005666_abnormal_adipose_tissue | 0.44322175 |
111 | MP0001765_abnormal_ion_homeostasis | 0.44157504 |
112 | MP0009115_abnormal_fat_cell | 0.43002403 |
113 | MP0001270_distended_abdomen | 0.42842445 |
114 | MP0005410_abnormal_fertilization | 0.42286680 |
115 | MP0002168_other_aberrant_phenotype | 0.42280082 |
116 | MP0003315_abnormal_perineum_morphology | 0.41716146 |
117 | MP0000230_abnormal_systemic_arterial | 0.41202836 |
118 | MP0003566_abnormal_cell_adhesion | 0.38514909 |
119 | MP0002697_abnormal_eye_size | 0.37675309 |
120 | MP0000249_abnormal_blood_vessel | 0.37374021 |
121 | MP0003115_abnormal_respiratory_system | 0.35872891 |
122 | MP0004043_abnormal_pH_regulation | 0.35178340 |
123 | MP0003631_nervous_system_phenotype | 0.34627749 |
124 | MP0009780_abnormal_chondrocyte_physiolo | 0.34574807 |
125 | MP0003075_altered_response_to | 0.34499969 |
126 | MP0003943_abnormal_hepatobiliary_system | 0.33797100 |
127 | MP0002128_abnormal_blood_circulation | 0.33623450 |
128 | MP0000427_abnormal_hair_cycle | 0.31920789 |
129 | MP0008874_decreased_physiological_sensi | 0.31763959 |
130 | MP0009672_abnormal_birth_weight | 0.31759707 |
131 | MP0003436_decreased_susceptibility_to | 0.30434774 |
132 | MP0002295_abnormal_pulmonary_circulatio | 0.29194431 |
133 | MP0002970_abnormal_white_adipose | 0.28752880 |
134 | MP0000579_abnormal_nail_morphology | 0.28521158 |
135 | MP0002796_impaired_skin_barrier | 0.28035029 |
136 | MP0002090_abnormal_vision | 0.27902906 |
137 | MP0001845_abnormal_inflammatory_respons | 0.26944583 |
138 | MP0005164_abnormal_response_to | 0.26821871 |
139 | MP0005452_abnormal_adipose_tissue | 0.25253738 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 7.42510682 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.24276565 |
3 | Deep venous thrombosis (HP:0002625) | 7.11895297 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.57967725 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 6.40180058 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.27259855 |
7 | Xanthomatosis (HP:0000991) | 6.11922438 |
8 | Complement deficiency (HP:0004431) | 5.60071219 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.23816603 |
10 | Abnormality of the common coagulation pathway (HP:0010990) | 5.16401995 |
11 | Hypolipoproteinemia (HP:0010981) | 4.78808222 |
12 | Joint hemorrhage (HP:0005261) | 4.55380385 |
13 | Epidermoid cyst (HP:0200040) | 4.52593968 |
14 | Conjugated hyperbilirubinemia (HP:0002908) | 4.40070654 |
15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.35089431 |
16 | Abnormality of the intrinsic pathway (HP:0010989) | 4.28761526 |
17 | Hypoglycemic coma (HP:0001325) | 4.28251120 |
18 | Ketosis (HP:0001946) | 4.25449919 |
19 | Hypoalphalipoproteinemia (HP:0003233) | 4.25416821 |
20 | Hyperammonemia (HP:0001987) | 4.23822822 |
21 | Fat malabsorption (HP:0002630) | 4.16945094 |
22 | Abnormality of methionine metabolism (HP:0010901) | 4.13043669 |
23 | Abnormality of complement system (HP:0005339) | 4.04043197 |
24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.02462760 |
25 | Hyperglycinemia (HP:0002154) | 4.02359413 |
26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.95439372 |
27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.85871011 |
28 | Hyperglycinuria (HP:0003108) | 3.65344002 |
29 | Abnormality of glycine metabolism (HP:0010895) | 3.58517459 |
30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.58517459 |
31 | Hyperbilirubinemia (HP:0002904) | 3.51684362 |
32 | Ketoacidosis (HP:0001993) | 3.41741059 |
33 | Hypercholesterolemia (HP:0003124) | 3.39184086 |
34 | Spontaneous abortion (HP:0005268) | 3.37378625 |
35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.27727482 |
36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.20507854 |
37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.17161014 |
38 | Nephritis (HP:0000123) | 3.11990489 |
39 | Skin nodule (HP:0200036) | 3.08803139 |
40 | Osteomalacia (HP:0002749) | 3.07798008 |
41 | Hypochromic microcytic anemia (HP:0004840) | 3.00143212 |
42 | Hypoglycemic seizures (HP:0002173) | 2.97521377 |
43 | Purpura (HP:0000979) | 2.95481701 |
44 | Hepatocellular carcinoma (HP:0001402) | 2.87614955 |
45 | Delayed CNS myelination (HP:0002188) | 2.86346337 |
46 | Arthropathy (HP:0003040) | 2.82640444 |
47 | Steatorrhea (HP:0002570) | 2.79095776 |
48 | Abnormality of nucleobase metabolism (HP:0010932) | 2.77668577 |
49 | Abnormality of carpal bone ossification (HP:0006257) | 2.77667529 |
50 | Acanthocytosis (HP:0001927) | 2.77446331 |
51 | Myocardial infarction (HP:0001658) | 2.76415583 |
52 | Abnormality of serum amino acid levels (HP:0003112) | 2.72667936 |
53 | Abnormal tarsal ossification (HP:0008369) | 2.71537969 |
54 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.65454105 |
55 | Metabolic acidosis (HP:0001942) | 2.61145395 |
56 | Abnormal gallbladder morphology (HP:0012437) | 2.60093015 |
57 | Systemic lupus erythematosus (HP:0002725) | 2.59381641 |
58 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58613960 |
59 | Abnormality of purine metabolism (HP:0004352) | 2.56248939 |
60 | Gingival bleeding (HP:0000225) | 2.52577362 |
61 | Glomerulonephritis (HP:0000099) | 2.51335648 |
62 | Hyperglycemia (HP:0003074) | 2.48344721 |
63 | Hypophosphatemic rickets (HP:0004912) | 2.42905213 |
64 | Mitral stenosis (HP:0001718) | 2.42621566 |
65 | Lethargy (HP:0001254) | 2.42446215 |
66 | Gout (HP:0001997) | 2.41287076 |
67 | Amyloidosis (HP:0011034) | 2.39279192 |
68 | Spastic diplegia (HP:0001264) | 2.38852884 |
69 | Cholecystitis (HP:0001082) | 2.38495860 |
70 | Abnormal gallbladder physiology (HP:0012438) | 2.38495860 |
71 | Irritability (HP:0000737) | 2.36730227 |
72 | Flat acetabular roof (HP:0003180) | 2.34727184 |
73 | Late onset (HP:0003584) | 2.34138650 |
74 | Cholelithiasis (HP:0001081) | 2.32534179 |
75 | Small epiphyses (HP:0010585) | 2.29978140 |
76 | Dicarboxylic aciduria (HP:0003215) | 2.29295782 |
77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.29295782 |
78 | Cerebral edema (HP:0002181) | 2.28503585 |
79 | Broad alveolar ridges (HP:0000187) | 2.26141304 |
80 | Esophageal varix (HP:0002040) | 2.21848428 |
81 | Vascular calcification (HP:0004934) | 2.21078187 |
82 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.19454296 |
83 | Enlarged kidneys (HP:0000105) | 2.18867483 |
84 | Reduced antithrombin III activity (HP:0001976) | 2.18772236 |
85 | Menorrhagia (HP:0000132) | 2.18083708 |
86 | Pancreatitis (HP:0001733) | 2.17625183 |
87 | Thrombophlebitis (HP:0004418) | 2.16643809 |
88 | Pulmonary embolism (HP:0002204) | 2.12899320 |
89 | Neonatal onset (HP:0003623) | 2.12752893 |
90 | Sensorimotor neuropathy (HP:0007141) | 2.12198543 |
91 | Generalized aminoaciduria (HP:0002909) | 2.07008586 |
92 | Abnormal hand bone ossification (HP:0010660) | 2.06062055 |
93 | Symptomatic seizures (HP:0011145) | 2.05818795 |
94 | Abnormality of the gallbladder (HP:0005264) | 2.04598734 |
95 | Abnormal ossification of hand bones (HP:0005921) | 2.02414323 |
96 | Potter facies (HP:0002009) | 2.01648550 |
97 | Facial shape deformation (HP:0011334) | 2.01648550 |
98 | Abnormality of the Achilles tendon (HP:0005109) | 2.00587842 |
99 | Abnormality of the lumbar spine (HP:0100712) | 1.99103674 |
100 | Increased serum pyruvate (HP:0003542) | 1.98829023 |
101 | Brushfield spots (HP:0001088) | 1.96490120 |
102 | Malnutrition (HP:0004395) | 1.95909888 |
103 | Hepatoblastoma (HP:0002884) | 1.95448992 |
104 | Cardiovascular calcification (HP:0011915) | 1.95155841 |
105 | Renal cortical cysts (HP:0000803) | 1.93931172 |
106 | Peritonitis (HP:0002586) | 1.93882187 |
107 | Abnormal delivery (HP:0001787) | 1.91703940 |
108 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91250192 |
109 | Abnormality of the nasal septum (HP:0000419) | 1.91028948 |
110 | Poikilocytosis (HP:0004447) | 1.90815652 |
111 | Vomiting (HP:0002013) | 1.90524229 |
112 | Epistaxis (HP:0000421) | 1.89214169 |
113 | Abnormality of vitamin metabolism (HP:0100508) | 1.88631781 |
114 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.87754336 |
115 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.87754336 |
116 | Broad palm (HP:0001169) | 1.86630224 |
117 | Retinal atrophy (HP:0001105) | 1.85339213 |
118 | Rickets (HP:0002748) | 1.85153936 |
119 | Abnormality of iron homeostasis (HP:0011031) | 1.83622755 |
120 | Joint swelling (HP:0001386) | 1.82292983 |
121 | Proximal tubulopathy (HP:0000114) | 1.80951292 |
122 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80473419 |
123 | Opisthotonus (HP:0002179) | 1.78029571 |
124 | Elevated hepatic transaminases (HP:0002910) | 1.77347166 |
125 | Hydroxyprolinuria (HP:0003080) | 1.76311338 |
126 | Abnormality of proline metabolism (HP:0010907) | 1.76311338 |
127 | Hemorrhage of the eye (HP:0011885) | 1.75460187 |
128 | Abnormality of glycolysis (HP:0004366) | 1.74464446 |
129 | Abnormal cartilage morphology (HP:0002763) | 1.73113467 |
130 | Increased serum ferritin (HP:0003281) | 1.72040148 |
131 | Vaginal fistula (HP:0004320) | 1.71435009 |
132 | Abnormal foot bone ossification (HP:0010675) | 1.69429050 |
133 | Hyperphosphaturia (HP:0003109) | 1.66530952 |
134 | Asymmetry of the thorax (HP:0001555) | 1.64984333 |
135 | Epiphyseal dysplasia (HP:0002656) | 1.64346160 |
136 | Fair hair (HP:0002286) | 1.61985261 |
137 | Flared iliac wings (HP:0002869) | 1.60837963 |
138 | Widely patent fontanelles and sutures (HP:0004492) | 1.60428022 |
139 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.58412439 |
140 | Mucopolysacchariduria (HP:0008155) | 1.58412439 |
141 | Diastasis recti (HP:0001540) | 1.57906294 |
142 | Submucous cleft hard palate (HP:0000176) | 1.57683224 |
143 | Abnormality of pain sensation (HP:0010832) | 1.56538209 |
144 | Impaired pain sensation (HP:0007328) | 1.56538209 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.77818603 |
2 | TAOK3 | 5.29606618 |
3 | INSRR | 4.30278392 |
4 | FGFR4 | 4.07368270 |
5 | ERN1 | 3.84948023 |
6 | FRK | 3.53071256 |
7 | ICK | 3.45549044 |
8 | SIK1 | 3.41397883 |
9 | CDK12 | 3.05706697 |
10 | PIK3CA | 2.99342116 |
11 | TYRO3 | 2.84071850 |
12 | PIK3CG | 2.82814061 |
13 | ERBB4 | 2.68326569 |
14 | PKN2 | 2.54636566 |
15 | FLT3 | 2.21341110 |
16 | FGFR1 | 2.03381441 |
17 | MAP2K4 | 1.96931034 |
18 | MST1R | 1.92222210 |
19 | MAPK15 | 1.74874318 |
20 | PTK6 | 1.63759021 |
21 | WNK1 | 1.60394434 |
22 | TRIB3 | 1.58296952 |
23 | NEK9 | 1.57749012 |
24 | MAPK11 | 1.49336026 |
25 | EPHA3 | 1.48021919 |
26 | LATS1 | 1.45581312 |
27 | UHMK1 | 1.44647588 |
28 | EIF2AK1 | 1.44334021 |
29 | FGFR2 | 1.35389155 |
30 | JAK2 | 1.31804879 |
31 | RIPK1 | 1.30609794 |
32 | TYK2 | 1.28962125 |
33 | MAP3K2 | 1.25176941 |
34 | DAPK2 | 1.17838779 |
35 | SIK2 | 1.15205417 |
36 | EPHB1 | 1.12103967 |
37 | DDR2 | 1.07115613 |
38 | JAK1 | 1.06137265 |
39 | ABL2 | 0.97333836 |
40 | MET | 0.96427176 |
41 | PRKAA2 | 0.95881926 |
42 | PAK3 | 0.93163841 |
43 | ERBB2 | 0.89855224 |
44 | FGFR3 | 0.88550701 |
45 | FGR | 0.86985542 |
46 | SGK1 | 0.86613603 |
47 | GSK3A | 0.82919679 |
48 | PRKACG | 0.82616775 |
49 | EEF2K | 0.82524914 |
50 | RPS6KB1 | 0.80534596 |
51 | NTRK3 | 0.78920204 |
52 | CSNK1E | 0.78113651 |
53 | MAP3K7 | 0.77819278 |
54 | CDC42BPA | 0.77349053 |
55 | BCR | 0.77285897 |
56 | CDK7 | 0.76180750 |
57 | TBK1 | 0.73856390 |
58 | PRKAA1 | 0.73726317 |
59 | KDR | 0.73564446 |
60 | RET | 0.73052413 |
61 | EPHA4 | 0.73050564 |
62 | DYRK1B | 0.72572055 |
63 | SCYL2 | 0.70301428 |
64 | CAMK2G | 0.68528154 |
65 | NEK1 | 0.67444172 |
66 | LATS2 | 0.67375167 |
67 | PINK1 | 0.66593060 |
68 | MAP3K14 | 0.65696380 |
69 | CSK | 0.65436738 |
70 | MAP3K3 | 0.65309307 |
71 | PRKCZ | 0.65270877 |
72 | MAPK4 | 0.64828787 |
73 | STK39 | 0.63236101 |
74 | CSNK1D | 0.61367959 |
75 | MAPKAPK3 | 0.61296090 |
76 | PTK2 | 0.59004158 |
77 | WNK4 | 0.58903157 |
78 | MAP3K10 | 0.58741427 |
79 | CAMK1D | 0.57696828 |
80 | GRK6 | 0.56381479 |
81 | CDK6 | 0.55458254 |
82 | SGK3 | 0.54816732 |
83 | MAP3K5 | 0.53121247 |
84 | PDK2 | 0.51451180 |
85 | PDPK1 | 0.51441004 |
86 | IGF1R | 0.49387301 |
87 | CAMKK1 | 0.48247199 |
88 | CAMK1G | 0.48069394 |
89 | SRC | 0.47808439 |
90 | NLK | 0.46452494 |
91 | FER | 0.45548523 |
92 | PRKCQ | 0.45507164 |
93 | BRSK1 | 0.44497925 |
94 | CAMKK2 | 0.44235625 |
95 | NEK2 | 0.43725968 |
96 | MAP3K1 | 0.43197555 |
97 | BRSK2 | 0.43165299 |
98 | CSNK2A2 | 0.42350297 |
99 | PDK1 | 0.41632623 |
100 | KSR2 | 0.41623654 |
101 | MAP3K13 | 0.41176589 |
102 | MATK | 0.40738900 |
103 | SGK2 | 0.40504481 |
104 | HIPK2 | 0.40502152 |
105 | CSNK2A1 | 0.39814812 |
106 | CDK4 | 0.39744260 |
107 | PDGFRA | 0.39680453 |
108 | MAP2K6 | 0.39412337 |
109 | MAP2K1 | 0.39041272 |
110 | EPHA2 | 0.38227868 |
111 | LMTK2 | 0.38034419 |
112 | CSNK1G1 | 0.37966088 |
113 | BRD4 | 0.36967171 |
114 | MAP3K6 | 0.36388598 |
115 | PRKACB | 0.36327732 |
116 | STK38L | 0.36025805 |
117 | SGK494 | 0.35905963 |
118 | SGK223 | 0.35905963 |
119 | PRKCG | 0.35096109 |
120 | IRAK3 | 0.34870970 |
121 | EIF2AK3 | 0.34612426 |
122 | MAP2K3 | 0.34341530 |
123 | TIE1 | 0.34164610 |
124 | PKN1 | 0.34025576 |
125 | PRKCB | 0.33789373 |
126 | MAPK7 | 0.33345981 |
127 | CSNK1G2 | 0.32515879 |
128 | PRKCH | 0.31854738 |
129 | IRAK1 | 0.31774800 |
130 | MAP3K12 | 0.31690250 |
131 | EGFR | 0.30435193 |
132 | PDGFRB | 0.30262886 |
133 | PRKCA | 0.30113932 |
134 | MAP3K4 | 0.29928651 |
135 | MTOR | 0.29679152 |
136 | PRKD1 | 0.29432066 |
137 | MAPK12 | 0.28667735 |
138 | PDK3 | 0.28531533 |
139 | PDK4 | 0.28531533 |
140 | ITK | 0.28345823 |
141 | NTRK1 | 0.26840374 |
142 | CSF1R | 0.25107944 |
143 | IKBKE | 0.25010147 |
144 | GRK1 | 0.24838640 |
145 | RPS6KA3 | 0.23864540 |
146 | AKT3 | 0.23561850 |
147 | TGFBR2 | 0.23358787 |
148 | PRKG1 | 0.22160125 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.44471720 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.96232071 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.44484587 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.17643529 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99949042 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.91745553 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70929101 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67685040 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53059733 |
10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.51887479 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45066063 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.43068571 |
13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17593977 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.11457264 |
15 | Peroxisome_Homo sapiens_hsa04146 | 2.07473559 |
16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92569852 |
17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92261999 |
18 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.91329438 |
19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.86872109 |
20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85784583 |
21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85343068 |
22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.83092426 |
23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76916512 |
24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75196220 |
25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.69048788 |
26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.66010494 |
27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64923111 |
28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64841651 |
29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.63452139 |
30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60425825 |
31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60212243 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56743620 |
33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53167171 |
34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50583059 |
35 | Bile secretion_Homo sapiens_hsa04976 | 1.50360391 |
36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49051666 |
37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.48367653 |
38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43123419 |
39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34211788 |
40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.30503301 |
41 | ABC transporters_Homo sapiens_hsa02010 | 1.29792057 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29398248 |
43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28815441 |
44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26458442 |
45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26158855 |
46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24151796 |
47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.10142609 |
48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09711256 |
49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07393416 |
50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97046941 |
51 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91749031 |
52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89048489 |
53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86578853 |
54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86358318 |
55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83234582 |
56 | Lysine degradation_Homo sapiens_hsa00310 | 0.80018704 |
57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79871978 |
58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76116795 |
59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74550882 |
60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70082294 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66893489 |
62 | Prion diseases_Homo sapiens_hsa05020 | 0.66499853 |
63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63656184 |
64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59882537 |
65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55477658 |
66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55464183 |
67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53104379 |
68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51746462 |
69 | Pertussis_Homo sapiens_hsa05133 | 0.48746332 |
70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44269139 |
71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44007410 |
72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42828100 |
73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36078136 |
74 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35277951 |
75 | Insulin resistance_Homo sapiens_hsa04931 | 0.34744575 |
76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28420452 |
77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26772877 |
78 | Protein export_Homo sapiens_hsa03060 | 0.26565878 |
79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26356209 |
80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23518845 |
81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22982554 |
82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17899686 |
83 | Mineral absorption_Homo sapiens_hsa04978 | 0.16439804 |
84 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14119956 |
85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.12690417 |
86 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.10536945 |
87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.07105683 |
88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06336699 |
89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.05646914 |
90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.01395094 |
91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.00353239 |
92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1854850 |
93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1843645 |
94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1741995 |
95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1693671 |
96 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1693514 |
97 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1483504 |
98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1248530 |
99 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1189588 |
100 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1141223 |
101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1127608 |
102 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1018557 |
103 | Lysosome_Homo sapiens_hsa04142 | -0.0890131 |
104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0855683 |
105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0726423 |
106 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0722956 |
107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0696068 |
108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0378100 |
109 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0237285 |
110 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0118359 |
111 | Amoebiasis_Homo sapiens_hsa05146 | -0.0030490 |